Viewing Study NCT03681457


Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2026-01-31 @ 12:28 AM
Study NCT ID: NCT03681457
Status: COMPLETED
Last Update Posted: 2020-12-14
First Post: 2018-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-alcoholic Fatty Liver Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None safety View
None LJN452 View
None tropifexor View
None PK View
None healthy subjects View
None hepatically impaired View
None Nonalcoholic Steatohepatitis View
None Nonalcoholic Fatty Liver Disease View
None NAFLD View